Navigation Links
From outer space to the eye clinic: New cataract early detection technique
Date:1/12/2009

A compact fiber-optic probe developed for the space program has now proven valuable for patients in the clinic as the first non-invasive early detection device for cataracts, the leading cause of vision loss worldwide.

Researchers from the National Eye Institute (NEI), part of the National Institutes of Health, and the National Aeronautics and Space Administration (NASA) collaborated to develop a simple, safe eye test for measuring a protein related to cataract formation. If subtle protein changes can be detected before a cataract develops, people may be able to reduce their cataract risk by making simple lifestyle changes, such as decreasing sun exposure, quitting smoking, stopping certain medications and controlling diabetes.

"By the time the eye's lens appears cloudy from a cataract, it is too late to reverse or medically treat this process," said Manuel B. Datiles III, M.D., NEI medical officer and lead author of the clinical study. "This technology can detect the earliest damage to lens proteins, triggering an early warning for cataract formation and blindness."

The new device is based on a laser light technique called dynamic light scattering (DLS). It was initially developed to analyze the growth of protein crystals in a zero-gravity space environment. NASA's Rafat R. Ansari, Ph.D., senior scientist at the John H. Glenn Research Center and co-author of the study, brought the technology's possible clinical applications to the attention of NEI vision researchers when he learned that his father's cataracts were caused by changes in lens proteins.

Several proteins are involved in cataract formation, but one known as alpha-crystallin serves as the eye's own anti-cataract molecule. Alpha-crystallin binds to other proteins when they become damaged, thus preventing them from bunching together to form a cataract. However, humans are born with a fixed amount of alpha-crystallin, so if the supply becomes depleted due to radiatio
'/>"/>

Contact: NEI News Office
neinews@nei.nih.gov
301-496-5248
NIH/National Eye Institute
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Space scientists, humanist scholars to explore outer space from new perspective
2. CBS Outernet Partners With Lifeclinic International to Bring Interactive Health Programming and Advertising to Pharmacy Locations Nationwide
3. CBS Outernet and Lifeclinic To Show Wellness Channel at NACDS Marketplace
4. Special Summer Camp Helps Girls Recognize Inner and Outer Beauty
5. Agito Networks RoamAnywhere Mobility Router Wins Unified Communications Magazines 2008 UC Excellence Award
6. NASA and NIH Partner for Health Research in Space
7. Sensitivity of brain center for sound space defined
8. Greeks get space-based help in wake of deadly fires
9. Small Bone Innovations Introduces the Artelon(R) STT Spacer to Increase Treatment Options for Thumb Arthritis
10. NASA, NSBRI Select 17 Proposals in Space Radiation Research
11. Randolph Equities to Break Ground on State of the Art Medical Center in Space Starved Near West Chicago Suburbs

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/28/2009)...nsider change after 30-minute psychosocial interve...HealthDay News) -- A program that gets persistent ...ir dangerous behavior may lead to significant and ... The new study included 184 men and women with two...ere randomly assigned to one of two interventions....
(Date:11/27/2009)...Replikins Ltd. today issued its latest biochemical...s that the lethality of the virus has dropped from...rent outbreak in the spring of 2009 to resting non...H1N1 infectivity count, however, remains increased...er 27, 2009 -- Biotech firm Replikins Ltd., which ...
(Date:11/27/2009)... 27 Shamir Optical Indus...provider of innovative products and technology to ...ts board of directors had declared a dividend dist...(approximately NIS 37.62 million based on the Nove... approximately US$ 0.609 (approximately NIS 2.3 ba...
(Date:11/27/2009)...™ announced today that Spectrum Health (Gran...erprise orthopedic templating solution and its Tra... (PRWEB) November 27, 2009 -- Voyant Heal...and Rapids, Michigan) has licensed its TraumaCad E...raumaCad Extend workflow solution, to allow its or...
(Date:11/26/2009)... The diabetes population in the Uni...rs and annual medical spending on the disease is p... today, according to a study published in the Dece...ging Diabetes ® Program (NCDP), a program of ...from the University of Chicago. ,, According to...
Breaking Medicine News(10 mins):Health News:Drunk Drivers May Respond to Brief Motivational Interview 2Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 2Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 3Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 4Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 5Health News:Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 2Health News:Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 3Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 2Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 3Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 2Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 3Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 4
...ysician Hospitals of America (PHA) congratulates C...l provide healthcare access and insurance to milli...HA Executive Director. "Congress recognized that ...priately attached to this important package." , ,...
...g Innovations, Inc.,(Nasdaq: YDNT ) today announ...r,31, 2008. , Sales for the fourth quarter of ...n, or 4.5%, from the $25.0 million reported in the...of 2008. Net,income declined 13.0% to $3.1 millio...
...ton John AIDS Foundation announced today that Gram... the 17th Annual Elton John AIDS Foundation (EJAF)...ry 22, 2009, at the Pacific Design Center in Los A...Oakland native Raphael Saadiq made his entree into...
... MedCath Corporation,(Nasdaq: MDTH ), a healthc...vices, predominately the diagnosis and treatment o...ting results for its first quarter of fiscal 2009,... million, -- Operating cash flow from continuin...
...Pharmaceutical Research and Manufacturers of Ameri...he following statement today regarding the State C... Act: , , "President Obama,s signing into law an ...and, indeed, for all Americans -- for we are the f...
...igars at Cigarette Equivalent for First Time , , ...rt indicates a dramatic increase in the use of cig...troubling trend given the popularity of these prod...sumption increased 240 percent, while cigarillos i...
Other Medicine News:Health News:Physician Hospitals of America (PHA) Congratulates Congress on its Passage of a 'Clean' SCHIP Children's Health Bill 2Health News:Young Innovations, Inc. Announces Results for 4th Quarter and the Year and Declares Dividend 2Health News:Young Innovations, Inc. Announces Results for 4th Quarter and the Year and Declares Dividend 3Health News:Young Innovations, Inc. Announces Results for 4th Quarter and the Year and Declares Dividend 4Health News:Young Innovations, Inc. Announces Results for 4th Quarter and the Year and Declares Dividend 5Health News:Young Innovations, Inc. Announces Results for 4th Quarter and the Year and Declares Dividend 6Health News:Young Innovations, Inc. Announces Results for 4th Quarter and the Year and Declares Dividend 7Health News:Three-Time Grammy Nominee Raphael Saadiq to Perform at 17th Annual Elton John AIDS Foundation Academy Awards(R) Viewing Party 2Health News:Three-Time Grammy Nominee Raphael Saadiq to Perform at 17th Annual Elton John AIDS Foundation Academy Awards(R) Viewing Party 3Health News:Three-Time Grammy Nominee Raphael Saadiq to Perform at 17th Annual Elton John AIDS Foundation Academy Awards(R) Viewing Party 4Health News:MedCath Corporation Reports First Quarter Earnings 2Health News:MedCath Corporation Reports First Quarter Earnings 3Health News:MedCath Corporation Reports First Quarter Earnings 4Health News:MedCath Corporation Reports First Quarter Earnings 5Health News:MedCath Corporation Reports First Quarter Earnings 6Health News:MedCath Corporation Reports First Quarter Earnings 7Health News:MedCath Corporation Reports First Quarter Earnings 8Health News:MedCath Corporation Reports First Quarter Earnings 9Health News:MedCath Corporation Reports First Quarter Earnings 10Health News:MedCath Corporation Reports First Quarter Earnings 11Health News:MedCath Corporation Reports First Quarter Earnings 12Health News:MedCath Corporation Reports First Quarter Earnings 13Health News:MedCath Corporation Reports First Quarter Earnings 14Health News:PhRMA Statement on Expansion of SCHIP 2Health News:Little Cigar Consumption on the Rise, While Cigarette Use Declines 2Health News:Little Cigar Consumption on the Rise, While Cigarette Use Declines 3Health News:Little Cigar Consumption on the Rise, While Cigarette Use Declines 4
(Date:11/25/2009)...ATER, N.J., Nov. 25 The FDA grante...rine) tablets, a non-nucleoside reverse transcript... specifically indicated for use in treatment-exper...re with HIV-1 strains resistant to an NNRTI and ot...approval is based on 48-week data from two Phase 3...
(Date:11/25/2009)...EGE PARK, Md., Nov. 25 ... shaving cream-like foam that stops severe bleedin...ng Security Idea category of the Global Security C..., Selected from more than 100 entries from arou...ion at the GSC Security Summit conference held at ...
(Date:11/25/2009)...NG RIDGE, N.J., Nov. 25 Regado Bio...elopment of antithrombotic aptamers with active co... and President, will be presenting at the Piper Ja...w York Palace Hotel in New York City. Dr. Mazzo,s...sday, December 1 and will include an overview of t...
Breaking Medicine Technology:U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 2U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 3U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 4U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 5Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 2Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 3Regado Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference on December 1, 2009 2U S Foodservice Cites Critical Need for Food Safety Culture From Farm to Fork During Monterey PMA Conference 52857 1U S Foodservice Cites Critical Need for Food Safety Culture From Farm to Fork During Monterey PMA Conference 52857 2U S Foodservice Cites Critical Need for Food Safety Culture From Farm to Fork During Monterey PMA Conference 52857 3Mayo researchers find anesthesia not harmful for babies during birth process 52855 1Mayo researchers find anesthesia not harmful for babies during birth process 52855 2Mayo researchers find anesthesia not harmful for babies during birth process 52855 3All in 1 nanoparticle 3A A Swiss Army knife for nanomedicine 9381 1All in 1 nanoparticle 3A A Swiss Army knife for nanomedicine 9381 2All in 1 nanoparticle 3A A Swiss Army knife for nanomedicine 9381 3
...on at ASCO Plenary Session Reports EORTC 40983 (EP...07 /PRNewswire-FirstCall/ -- Results of the,random...OC study,demonstrate for the first time that peri...n(R) (oxaliplatin injection) in,combination with a...-fluorouracil/leucovorin (5-FU/LV)) given to patie...
...Clinical Data on Thalidomide in Multiple Myeloma,P...ogy 43rd Annual,Meeting, CHICAGO, June 04, 2007 /P... reported the final results of a Phase III study,d...tandard therapy,improves overall survival (OS) by ...y diagnosed multiple myeloma compared to the,curre...
Other Medicine Technology:The Eloxatin-Based Regimen (FOLFOX4) Significantly Improved,Progression Free Survival When Given Before and After Surgery in,Patients With Resectable Liver Metastases From Colorectal Cancer 2The Eloxatin-Based Regimen (FOLFOX4) Significantly Improved,Progression Free Survival When Given Before and After Surgery in,Patients With Resectable Liver Metastases From Colorectal Cancer 3The Eloxatin-Based Regimen (FOLFOX4) Significantly Improved,Progression Free Survival When Given Before and After Surgery in,Patients With Resectable Liver Metastases From Colorectal Cancer 4The Eloxatin-Based Regimen (FOLFOX4) Significantly Improved,Progression Free Survival When Given Before and After Surgery in,Patients With Resectable Liver Metastases From Colorectal Cancer 5The Eloxatin-Based Regimen (FOLFOX4) Significantly Improved,Progression Free Survival When Given Before and After Surgery in,Patients With Resectable Liver Metastases From Colorectal Cancer 6The Eloxatin-Based Regimen (FOLFOX4) Significantly Improved,Progression Free Survival When Given Before and After Surgery in,Patients With Resectable Liver Metastases From Colorectal Cancer 7The Eloxatin-Based Regimen (FOLFOX4) Significantly Improved,Progression Free Survival When Given Before and After Surgery in,Patients With Resectable Liver Metastases From Colorectal Cancer 8The Eloxatin-Based Regimen (FOLFOX4) Significantly Improved,Progression Free Survival When Given Before and After Surgery in,Patients With Resectable Liver Metastases From Colorectal Cancer 9Adding Thalidomide to Standard Therapy Improves Survival in Newly,Diagnosed Multiple Myeloma Patients Over Age 75 2Adding Thalidomide to Standard Therapy Improves Survival in Newly,Diagnosed Multiple Myeloma Patients Over Age 75 3Adding Thalidomide to Standard Therapy Improves Survival in Newly,Diagnosed Multiple Myeloma Patients Over Age 75 4Adding Thalidomide to Standard Therapy Improves Survival in Newly,Diagnosed Multiple Myeloma Patients Over Age 75 5Adding Thalidomide to Standard Therapy Improves Survival in Newly,Diagnosed Multiple Myeloma Patients Over Age 75 6
Goat Anti-Mouse IgG Antibody, Gold Conjugated
Goat Anti-Human IgM Antibody, Gold Conjugated
Goat Anti-Human IgA, alpha chain Antibody, Colloidal Gold Conjugated, 50 OD
Protein A, Gold Ribbon - .13 OD per sq. cm.
Medicine Products: